Healthcare - Biotechnology - NASDAQ - GB
$ 1.79
-5.79 %
$ 7.77 M
Market Cap
-0.53
P/E
INCOME STATEMENT
156 K
REVENUE
-6.5 M
OPERATING INCOME
-6.74 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Virax Biolabs Group Limited
| Revenue | 156 K |
| Cost Of Revenue | 106 K |
| Gross Profit | 50.6 K |
| Operating Expenses | 6.55 M |
| Operating Income | -6.5 M |
| Other Expenses | 243 K |
| Net Income | -6.74 M |
Income Statement
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0.2 | 8.56 K | 0 | 0.1 | 99.9 K |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.1 | 9.93 K | 0 | 0.1 | 54.1 K |
| Gross Profit | 50.6 K | 1.36 K | 0 | 9.43 K | 45.7 K |
| OPERATING INCOME | |||||
| Operating Expenses | 6.5 | 5.7 | 1.7 | 0.6 | 0.7 |
| Selling, General and Administrative Expenses | 4.6 | 5.3 | 1.3 | 0.5 | 0.6 |
| Research and Development Expenses | 1.6 | 0.4 | 0.4 | 0.1 | 87 K |
| Operating Income | (6.5) | (5.7) | (1.7) | (0.6) | (0.7) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 26.9 K | 15.5 K | 15.4 K | 28.6 K | 90.7 K |
| Total Other Income | (0.2) | 0.3 | 16.2 K | 28.4 K | 88.2 K |
| Pre-Tax Income | (6.7) | (5.5) | (1.7) | (0.7) | (0.7) |
| NET INCOME | |||||
| Tax Provision | 0 | 271 | (1.8) | (0.7) | 61.7 K |
| Net Income | (6.7) | (5.5) | (1.7) | (0.7) | (0.8) |
| EPS | 3.36 | 5.13 | 1.5 | 0.57 | 0.7 |